These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 29623846

  • 1. Immune Mediated Necrotizing Myopathy: Where do we Stand?
    Mohammed AGA, Gcelu A, Moosajee F, Botha S, Kalla AA.
    Curr Rheumatol Rev; 2019; 15(1):23-26. PubMed ID: 29623846
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G, Antonini G, Garibaldi M.
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I.
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [Abstract] [Full Text] [Related]

  • 6. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L, Arouche-Delaperche L, Allenbach Y, Benveniste O.
    Curr Rheumatol Rep; 2018 Aug 03; 20(9):56. PubMed ID: 30074107
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C, Beaufrére AM, Boyer O, Drouot L, Soubrier M, Tournadre A.
    Joint Bone Spine; 2014 Jan 03; 81(1):79-82. PubMed ID: 23953224
    [Abstract] [Full Text] [Related]

  • 10. [Immune-Mediated Necrotizing Myopathy].
    Uruha A.
    Brain Nerve; 2024 May 03; 76(5):646-654. PubMed ID: 38741508
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review.
    Qiu R, Wang Z, Wei X, Sui H, Jiang Z, Yu XF.
    Biomed Pharmacother; 2022 Dec 03; 156():113936. PubMed ID: 36411623
    [Abstract] [Full Text] [Related]

  • 17. Management of immune-mediated necrotizing myopathy.
    Suh J, Amato AA.
    Muscle Nerve; 2024 Aug 03; 70(2):166-172. PubMed ID: 38801022
    [Abstract] [Full Text] [Related]

  • 18. Immune-mediated necrotising myopathy: A critical review of current concepts.
    Day JA, Limaye V.
    Semin Arthritis Rheum; 2019 Dec 03; 49(3):420-429. PubMed ID: 31109639
    [Abstract] [Full Text] [Related]

  • 19. [Clinical and pathological characteristics of immune mediated necrotizing myopathy].
    Yang HX, Tian XL, Jiang W, Li WL, Liu QY, Peng QL, Wang GC, Lu X.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec 18; 51(6):989-995. PubMed ID: 31848492
    [Abstract] [Full Text] [Related]

  • 20. Clinical and histological features of immune-mediated necrotising myopathy: A multi-centre South Australian cohort study.
    Day J, Otto S, Cash K, Limaye V.
    Neuromuscul Disord; 2020 Mar 18; 30(3):186-199. PubMed ID: 32229165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.